Jubilant Pharmova Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is OLANZAPINE USP (FORM-I), with a corresponding US DMF Number 20990.
Remarkably, this DMF maintains an Active status since its submission on October 22, 2007, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 23, 2012, and payment made on December 17, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II